CD274 and neoplasm: Genomic profiling of PD-L1+ PC-CTC could better characterize metastatic PCs compared to the evaluation of PD-L1 expression on primary tumor biopsies or prostatectomy specimens (sometimes sampled a long time before recurrence/progression).